Form Bio Co. Ltd. (377220) - Total Assets
Based on the latest financial reports, Form Bio Co. Ltd. (377220) holds total assets worth ₩75.59 Billion KRW (≈ $51.22 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore Form Bio Co. Ltd. cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Form Bio Co. Ltd. - Total Assets Trend (2019–2024)
This chart illustrates how Form Bio Co. Ltd.'s total assets have evolved over time, based on quarterly financial data. See Form Bio Co. Ltd. book value and equity for net asset value and shareholders' equity analysis.
Form Bio Co. Ltd. - Asset Composition Analysis
Current Asset Composition (December 2024)
Form Bio Co. Ltd.'s total assets of ₩75.59 Billion consist of 35.7% current assets and 64.3% non-current assets.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 2.4% |
| Accounts Receivable | ₩2.90 Billion | 3.6% |
| Inventory | ₩19.56 Billion | 24.1% |
| Property, Plant & Equipment | ₩0.00 | 0.0% |
| Intangible Assets | ₩2.68 Billion | 3.3% |
| Goodwill | ₩0.00 | 0.0% |
Asset Composition Trend (2019–2024)
This chart illustrates how Form Bio Co. Ltd.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see 377220 market cap overview.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Form Bio Co. Ltd.'s current assets represent 35.7% of total assets in 2024, a decrease from 64.2% in 2019.
- Cash Position: Cash and equivalents constituted 2.4% of total assets in 2024, up from 0.0% in 2019.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 3.0% of total assets, a decrease from 5.0% in 2019.
- Asset Diversification: The largest asset category is inventory at 24.1% of total assets.
Form Bio Co. Ltd. Competitors by Total Assets
Key competitors of Form Bio Co. Ltd. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Saputo Inc
TO:SAP
|
Canada | CA$13.61 Billion |
|
Orkla ASA
OL:ORK
|
Norway | Nkr88.70 Billion |
|
Tingyi (Cayman Islands) Holding Corp
F:TYG
|
Germany | €54.94 Billion |
|
Maple Leaf Foods Inc.
TO:MFI
|
Canada | CA$4.45 Billion |
|
Grupo Herdez S.A.B. de C.V
MX:HERDEZ
|
Mexico | MX$35.95 Billion |
|
Scandi Standard publ AB
ST:SCST
|
Sweden | Skr7.65 Billion |
|
Kri-Kri Milk Industry S.A
AT:KRI
|
Greece | €219.80 Million |
|
Namchow Food Group (Shanghai) Co. Ltd.
SHG:605339
|
China | CN¥4.18 Billion |
Form Bio Co. Ltd. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.69 | 1.41 | 4.10 |
| Quick Ratio | 0.24 | 0.50 | 2.78 |
| Cash Ratio | 0.00 | 0.27 | 0.26 |
| Working Capital | ₩-11.39 Billion | ₩10.67 Billion | ₩38.35 Billion |
Form Bio Co. Ltd. - Advanced Valuation Insights
This section examines the relationship between Form Bio Co. Ltd.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.06 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -16.6% |
| Total Assets | ₩81.18 Billion |
| Market Capitalization | $9.84 Million USD |
Valuation Analysis
Below Book Valuation: The market values Form Bio Co. Ltd.'s assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Form Bio Co. Ltd.'s assets decreased by 16.6% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Form Bio Co. Ltd. (2019–2024)
The table below shows the annual total assets of Form Bio Co. Ltd. from 2019 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | ₩81.18 Billion ≈ $55.01 Million |
-16.63% |
| 2023-12-31 | ₩97.36 Billion ≈ $65.98 Million |
+3.77% |
| 2022-12-31 | ₩93.82 Billion ≈ $63.58 Million |
-2.69% |
| 2021-12-31 | ₩96.41 Billion ≈ $65.34 Million |
+114.29% |
| 2020-12-31 | ₩44.99 Billion ≈ $30.49 Million |
+85.62% |
| 2019-12-31 | ₩24.24 Billion ≈ $16.43 Million |
-- |
About Form Bio Co. Ltd.
From Bio Co.,Ltd manufactures and sells health related products in South Korea. It offers health functional food, health beauty, and living health products. The company also provides cosmetic products under the Mastina and HYCL brands. In addition, it operates an online platform to retail its products. The company was founded in 2006 and is headquartered in Suwon-si, South Korea.